Editorial
doi: 10.1046/j.1468-2982.1998.1801005.x.
Neurogenic vs vascular mechanisms of sumatriptan and ergot alkaloids in migraine
- PMID: 9601617
- DOI: 10.1046/j.1468-2982.1998.1801005.x
Item in Clipboard
Editorial
Neurogenic vs vascular mechanisms of sumatriptan and ergot alkaloids in migraine
Cephalalgia.
1998 Jan.
No abstract available
Comment on
-
Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.Cephalalgia. 1997 Dec;17(8):833-42. doi: 10.1046/j.1468-2982.1997.1708833.x. Cephalalgia. 1997. PMID: 9453271 Clinical Trial.
Similar articles
-
Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats.Eur J Neurosci. 2001 Jun;13(11):2099-104. doi: 10.1046/j.0953-816x.2001.01586.x. Eur J Neurosci. 2001. PMID: 11422450
-
Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine.Trends Pharmacol Sci. 1992 Aug;13(8):307-11. doi: 10.1016/0165-6147(92)90097-p. Trends Pharmacol Sci. 1992. PMID: 1329294 Review.
-
The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.Eur J Pharmacol. 2000 Jun 9;398(1):73-81. doi: 10.1016/s0014-2999(00)00240-5. Eur J Pharmacol. 2000. PMID: 10856450
-
Neurogenic inflammation in the context of migraine.Microsc Res Tech. 2001 May 1;53(3):167-78. doi: 10.1002/jemt.1081. Microsc Res Tech. 2001. PMID: 11301492 Review.
-
Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.Cephalalgia. 1991 Sep;11(4):165-8. doi: 10.1046/j.1468-2982.1991.1104165.x. Cephalalgia. 1991. PMID: 1660351
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
